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ABSTRACT 
BACKGROUND: An increasing number of sporting bodies report unacceptably high levels of 
false positive electrocardiograms (ECGs) when undertaking pre-participation cardiac screening. 
To address this issue, modified ECG interpretation criteria have become available for use within 
athletes.  
OBJECTIVE: This study assessed the accuracy of the new 2014 ‘Refined Criteria’ against the 
2013 Seattle Criteria and the 2010 European Society of Cardiology (ESC) recommendations in a 
cohort of Arabic, Black and Caucasian athletes. 
METHODS: 2491 male athletes (1367 Arabic, 748 Black and 376 Caucasian) undertook pre-
participation screening including a 12-Lead ECG; with further investigation(s) upon indication. 
 
RESULTS: Ten athletes (0.4%) were identified with cardiac pathology; 7 with hypertrophic 
cardiomyopathy (HCM; 5 Black and 2 Arabic) and 3 Arabs with Wolff-Parkinson-White 
syndrome (WPW). All 3 ECG criteria were 100% sensitive identifying all cases of HCM and 
WPW.  The 2014 Refined Criteria reduced (p<0.0001) the prevalence of an abnormal ECG to 
5.3% vs. 11.6% (Seattle Criteria) and 22.3% (2010 ESC recommendations). The 2014 Refined 
Criteria significantly (p<0.0001) improved specificity (94.0%) across all ethnicities compared to 
the Seattle Criteria (87.5%) and ESC recommendations (76.6%).  Black athletes continue to 
present a higher prevalence (p<0.0001) of abnormal ECGs compared to Arabic and Caucasian 
athletes (10% vs. 3.6% and 2.1%).  
CONCLUSION: The 2014 Refined Criteria for athlete ECG interpretation outperformed both 
the 2013 Seattle Criteria and the 2010 ESC recommendations by significantly reducing the 
number of false-positive ECGs in Arabic, Black and Caucasian athletes whilst maintaining 100% 
sensitivity for serious cardiac pathologies.  
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What is already known about this subject? 
 The high rate of false positive ECGs in athletes is the main criticism of pre-participation 
screening with ECG. 
 The 2013 Seattle criteria improved the rate of false positive findings from that of the 
2010 ESC recommendations.   
 It has recently been proposed that atrial enlargement, axis deviation and right ventricular 
hypertrophy should not be classified as an abnormal finding in athletes if found in 
isolation.  Using this ‘Refined’ criterion, there is the potential to further reduce false 
positive findings. 
 
What does this study add? 
 The new 2014 Refined Criteria significantly improved specificity (94.0%) across all 
ethnicities compared to the 2012 Seattle Criteria and 2010 ESC recommendations (87.5% 
and 76.6% respectively). 
 It is possible to reduce abnormal ECG prevalence rates to 3.6% and 2.1% in Arabic and 
Caucasian athletes.  Whilst significantly reduced, however, the prevalence of abnormal 
ECGs in Black athletes continues to be 10% when using the 2014 Refined Criteria.        
 
How might this impact on clinical practice? 
 This study supports the rationale that when found in isolation, axis deviation, atrial 
enlargement and RVH are normal physiological ECG patterns in asymptomatic athletes 
without a family history of sudden cardiac death.   
 This study also highlights that these ECG patterns ought to be incorporated into pre-
existing ECG interpretational guidelines    
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INTRODUCTION 
In 2010, the European Society of Cardiology (ESC) produced ‘revised’ recommendations for the 
interpretation of electrocardiograms of athletes [1]. This was due to the increasing number of 
sporting governing bodies undertaking pre-participation cardiovascular screening reporting 
unacceptably high-levels of false positive ECGs arising from the overlap between physiological 
ECG patterns commonly observed in athletes, and those suggestive of cardiac pathology. To 
demonstrate improved specificity, the authors reanalysed the ECGs of 1,005 highly trained 
athletes previously reported a decade earlier [2]. Originally, 402 athletes (40%) presented an 
abnormal ECG (so called ‘Group 2’ changes) which was lowered to 11% using the 2010 ESC 
recommendations. Work from our group and others has, however, demonstrated that certain 
black ethnic populations, such as African, African-Caribbean and Black Latin-American, 
continue to demonstrate a high prevalence of abnormal ECGs (circa. 20-40%) when using the 
2010 ESC recommendations [3-6].  
 
To address this issue, in 2012 an international team of experts produced the ‘Seattle Criteria’ [7]; 
a revision of ECG interpretation guidelines for athletes, aimed to provide greater accuracy in 
identifying those with cardiac pathology, whilst also attempting to reduce the false positive rate. 
The Seattle Criteria have demonstrated favourable results over the ESC recommendations, with a 
reduction in the number of ECGs previously considered abnormal (17 to 4%) in a population of 
high-level athletes, whilst still identifying all athletes with cardiac pathology [8]. Furthermore, 
the Seattle Criteria considers specific ethnic ECG facets such as anterior (V1-V4) T-wave 
inversion (commonly observed in up to 13% of Black athletes [4]), to represent an ethnically 
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benign variant of the 'athlete's heart in those of Black ethnicity, helping to reduce false positive 
rates further.  
 
Recently, Sheikh et al. [9] published additional ‘Refined Criteria’ for ECG interpretation, based 
upon their experience of screening thousands of athletes utilising both the ESC recommendations 
and the Seattle Criteria. Sheikh et al. [9] demonstrated that the ECG patterns of isolated atrial 
enlargement (left and right), axis deviation (left and right) and right ventricular hypertrophy 
found in both the ESC recommendations and the Seattle Criteria provided an extremely low 
diagnostic yield for cardiac pathology. A unique feature of this investigation was a validation 
assessment in 103 young athletes with confirmed hypertrophic cardiomyopathy (HCM) where by 
the Refined Criteria identified 98.1% of HCM cases. 
 
Whilst the ESC guidelines were initially considered acceptable for use within Arabic athletes [3], 
it is unknown if the Seattle Criteria or the Refined Criteria are clinically appropriate for 
differentiating physiological cardiac adaptation from inherited pathology associated with sudden 
cardiac death (SCD) in Arabic athletes.  Consequently, the aim of this investigation was to assess 
the accuracy of the new 2014 Refined Criteria versus the 2013 Seattle Criteria and the 2010 ESC 
recommendations in a large cohort of Arabic, Black and Caucasian athletes when undertaking 
mass pre-participation cardiovascular screening. 
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METHODS 
Ethical approval was obtained from Shafallah Medical Genetics Centre and the Qatar Anti-
Doping Laboratory ethics committee, with all athletes completing informed consent in either 
Arabic or English. 
 
Participants 
Between November 2010 and January 2014, 2491 male athletes (exercising ≥6 h/week) 
presented at Aspetar Orthopaedic Sports Medicine Hospital for pre-participation cardiac 
screening; of whom 1367 were Arabic, 748 Black and 376 Caucasian. Ethnicity was self-
determined by the athlete. Arabic athletes were recruited from seven Gulf States (Qatar, Bahrain, 
Oman, United Arab Emirates, Kuwait, Yemen and Saudi-Arabia) and seven Middle-Eastern 
countries (Egypt, Morocco, Algeria, Tunisia, Jordan, Palestine and Lebanon). Black athletes 
came from 9 African countries (Sudan, Somalia, Ghana, Nigeria, Chad, Ivory Coast, Senegal, 
Cameroon and Ethiopia), 3 Caribbean countries (Trinidad and Tobago, Jamaica and Cuba) and 
those that self-determined their ethnicity as Black from South America (Brazil, Colombia, 
Ecuador and Uruguay).  The vast majority of Caucasian athletes came from mainland Europe, 
Australia and North America with a small number from South America.  
 
Pre-participation cardiovascular screening 
All players were screened using a cardiovascular pre-competition medical assessment form. 
Athletes completed the questionnaire regarding family history and personal symptoms, together 
with measurements of height, body mass, left brachial artery blood pressure (BP) in 
collaboration with an Arabic, French or English-speaking cardiac nurse. Precordial auscultation 
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in supine and standing positions, and assessment for any physical characteristics of Marfan’s 
syndrome were undertaken by a Sports Medicine Physician. From 2491 athletes presenting for 
pre-participation cardiac screening, 1718 (68.7%) required both ECG and echocardiography as 
standard as part of sport or club requirements.  
 
Resting 12-lead ECG 
A 12 lead ECG was recorded on all athletes after a period of 5 minutes rest in the supine position 
using a GE Mac 5500 (New York, USA). A well-defined protocol for electrode placement was 
used throughout by a single physiologist. Six electrodes are placed on the chest in the following 
locations: V1, fourth intercostal space at the right sternal border; V2, fourth intercostal space at 
the left sternal border; V3, midway between V2 and V4; V4, fifth intercostal space in the 
midclavicular line; V5, in the horizontal plane of V4 at the anterior axillary line, or if the anterior 
axillary line is ambiguous, midway between V4 and V6; and V6, in the horizontal plane of V4 at 
the midaxillary line. Four limb lead electrodes were placed on the arms and legs distal to the 
shoulders and hips.   
 
 
Echocardiography 
Echocardiographic examination was performed using a commercially available ultrasound 
system (Philips, USA). Images of the heart were obtained in the standard planes [10], with 
cardiac structure and function evaluated with previously described criteria [3]. All 
echocardiograms were obtained and reported by a single echocardiographer. 
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Further evaluation and follow-up 
Athletes demonstrating symptoms, a family history of SCD, ECG abnormalities and/or 
echocardiographic abnormalities considered to represent pathology were investigated further.  
Subsequent studies included 24-hour ECG, maximal exercise testing and cardiac magnetic 
resonance imaging.  A diagnosis of disease was established using published criteria [11, 12].  
 
Retrospective ECG examination 
All 2491 ECGs were analysed retrospectively using the ESC recommendations, followed by the 
Seattle Criteria and Refined Criteria. During analysis, first and last authors were blinded to 
pathological findings in all athletes, with MGW providing final judgement on ECG normality or 
abnormality using each of the 3 ECG criteria. Electrocardiographic parameters used to define 
various ECG abnormalities for the 3 sets of criteria are presented in Table 1.  
 
Refined Criteria 
Differences between the ESC recommendations and the Seattle criteria can be observed in Table 
1.  Compared to the ESC recommendations and the Seattle Criteria, the unique aspect of the 
Refined Criteria is that athletes would not receive further cardiovascular evaluation when 
presenting with the following recognised training related ECG changes in isolation; 1) left atrial 
enlargement (LAE), 2) right atrial enlargement (RAE), 3) left axis deviation (LAD), 4) right axis 
deviation (RAD) and 5) Sokolow-Lyon voltage criteria for right ventricular hypertrophy (RVH).  
In line with the Seattle Criteria, a corrected (Bazett’s formula) QT interval (QTc) ≥470 
milliseconds (ms) in males and ≥480ms in females, and T-wave inversion preceded by convex 
ST-segment elevation in leads V1-V4 in asymptomatic Black athletes do not require further 
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investigation. However, importantly, the presence of 2 or more of the above ECG patterns would 
warrant secondary investigation (Figure 1) [9]. It is worth noting that the Refined Criteria are not 
an evolution of the 2012 Seattle Criteria, but uses ECG parameters from both the 2010 ESC 
recommendations and the Seattle Criteria. 
 
Statistical analysis 
Data was analysed using SPSS 21.0 (Illinois, USA); presented as mean ± SD (range) and 
percentage where appropriate.  One-way Analysis of Variance (ANOVA) using Bonferrroni 
adjustments (if applicable) was used to identify differences in athlete anthropometry. A Chi-
square test was used to compare the number of abnormal ECGs between the 3 ECG 
interpretation criteria and between athlete ethnicities.  Specificity and sensitivity for the 3 criteria 
were calculated in those athletes who undertook both ECG and echocardiography as part of club 
requirements; following which positive and negative likelihood ratios were calculated. A 
McNemar Chi-square test was used to compare specificity and positive likelihood ratios between 
criteria.  A p-value <0.05 was considered significant. 
 
RESULTS 
Athlete demographics  
Overall, Arabic athletes were younger than both Black and Caucasian athletes (21.3 ± 5.4 vs. 
24.1 ± 5.0 and 24.3 ± 5.4 years respectively; p<0.05). Arabic athletes had a smaller body surface 
area (BSA) than both Black and Caucasian athletes (1.87 ± 0.26m2 vs. 2.00 ± 0.28m2 vs. 2.14 ± 
0.26 m2, p<0.05).  Caucasian athletes presented a larger BSA than Black athletes (p<0.05).  
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Athletes competed in a range of competitive sports (n=27), with 4 high-intensity intermittent 
sports dominating participation rates [soccer (43.2%), handball (13.7%), volleyball (9.1%), and 
basketball (8.5%)]. 
 
Identification of cardiac pathology 
Ten athletes (0.6%) were identified with a cardiac pathology associated with SCD; 7 with HCM 
(5 Black and 2 Arabic) and 3 Arabic athletes with Wolff-Parkinson-White syndrome (WPW).  
All athletes with HCM presented with an abnormal ECG, but were diagnosed with pathology via 
a combination of echocardiography, 24 hour Holter, exercise stress testing and cardiac MRI.  
The incidence of HCM in Black athletes (0.9%) was five-times greater than in Arabic athletes 
(0.2%).  All athletes with HCM displayed T-wave inversion; 5 inferolateral, 1 isolated lateral and 
1 with anterior-inferior. Six of the 7 HCM athletes demonstrated ‘deep’ (>0.3 mV) T-wave 
inversion, ST-segment depression and Sokolow voltage criteria for left ventricular hypertrophy, 
calculated as the amplitude of the S wave in V1 plus the amplitude of the R wave in either V5 or 
V6 ≥3.5mV (mean 4.53 mV).  These 3 cases of WPW demonstrated a classical delta wave, a 
short PR interval together with a prolonged QRS duration.  All 3 athletes underwent 
electrophysiological study and ablation, returning to full competition following a 2-month post-
operative recovery period. 
 
Comparison of 3 ECG interpretation criteria 
The number of ECGs considered abnormal using the 3 criteria is presented in Table 2. From 
2491 athletes, 555 (22.3%) were considered to have an abnormal ECG according to the ESC 
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recommendations. The most common ECG abnormalities were a prolonged QT interval (26.1%), 
T-wave inversion (21.3%), right atrial enlargement (16.5%) and a short PR interval (12.4%). 
Black athletes were significantly more likely to present an abnormal ECG than Arabic and 
Caucasian athletes (29.9% vs. 19.1% and 18.6% respectively, p<0.0001).     
 
Compared to the ESC recommendations, utilisation of the Seattle Criteria significantly reduced 
the number of abnormal ECGs from 22.3% to 11.6% (a 48% reduction (p<0.0001)). The main 
two ECG parameters that accounted for the majority of this improvement were an increase in the 
QTc cut-offs (≥470 ms males and ≥480 ms females) and the acknowledgement that isolated 
anterior T-wave inversion in asymptomatic Black athletes is benign.  This spared 172 (6.9%) 
athletes from further investigation.  From the remaining abnormal ECGs, 54.6% were considered 
abnormal due to either isolated RAE (31.8%), LAE (13.1%), left and right axis deviation (5.2% 
and 3.1%) and RVH (1.4%). Pathological Q waves (27.0%) and other locations of T-wave 
inversion (23.2%) were also highly prevalent.  Black athletes were again significantly more 
likely to present an abnormal ECG than Arabic and Caucasian athletes (16.6% vs. 9.7% and 
8.5% respectively, p<0.0001). Yet across all 3 ethnicities, the number of abnormal ECGs were 
significantly reduced compared to the ESC recommendations (p<0.0001). 
 
Application of the Refined Criteria further reduced (p<0.0001) the number of abnormal ECGs in 
athletes to 5.3%. Compared to the ESC recommendations and the Seattle Criteria, this produced 
a 76% and 54% reduction in the number of abnormal ECGs, respectively.  However, Black 
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athletes continue to present a significantly higher (p<0.0001) prevalence of abnormal ECGs 
compared to Arabic and Caucasian athletes (10% vs. 3.6% and 2.1%).  
 
Sensitivity and specificity for the 3 ECG interpretation criteria 
From 2491 athletes screened, 1718 (68.7%) were required to undergo both ECG and 
echocardiography due to club requirements. This cohort also contained all of the pathological 
cases (7 HCM and 3 WPW) and was consequently used to calculate the incidence of serious 
pathology together with the sensitivity and specificity of the 3 ECG interpretation criteria (Table 
3). Compared to the ESC recommendations, the Seattle Criteria significantly improved 
specificity from 76.6% to 87.5%, whilst the Refined Criteria further improved specificity to 
94.0%. Amongst Black athletes, the Refined Criteria offered 90.2% specificity, compared to 
69.5% and 83.7% for the ESC recommendations and the Seattle Criteria respectively.  This 
significant improvement in specificity was also seen in Arabic athletes.  The Refined Criteria led 
to a significant improvement in specificity (95.6%), compared to 80.2% and 88.9% for the ESC 
recommendations and the Seattle Criteria respectively.  However, there was 100% sensitivity for 
all 3 ECG interpretation criteria which detected all 7 cases of HCM and 3 cases of WPW. 
 
DISCUSSION 
The correct differentiation of physiological adaptation owing to sustained and intensive exercise 
from an inherited or congenital cardiac pathology is paramount, in order to correctly identify 
athletes at risk of SCD.  The key finding from the current study is that the prevalence of an 
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abnormal ECG was significantly reduced to 5.3% when using the 2014 Refined Criteria 
compared to the 2013 Seattle Criteria (11.6%) and the 2010 ESC recommendations (22.3%) 
respectively; whilst all 3 ECG interpretation criteria proved 100% sensitive, identifying all cases 
of serious cardiac pathology. 
 
Our results demonstrate that when using the 2010 ESC recommendations, almost 1 in 5 Arabic, 1 
in 3 Black and 1 in 5 Caucasian athletes would require further investigation due to an abnormal 
ECG.  These high false positive rates certainly reinforce concerns voiced by the cardiovascular 
screening sceptics.  Whilst the ESC recommendations are based upon consensus rather than 
scientific evidence, the Seattle Criteria modified its ECG interpretation criteria by applying 
evidence that 1) accounted for the impact of African-Caribbean ethnicity upon the 
electrocardiographic patterns seen in athletes [4, 13, 14] and 2) by raising the QTc thresholds 
(≥470 ms men and ≥480 ms women) that would trigger further evaluation [15, 16].  By 
incorporating these two electrocardiographic features, our study demonstrates that 172 (6.9%) of 
athletes would be spared further investigation, helping to lower (p<0.0001) the prevalence of 
abnormal ECGs by 48% compared to the ESC recommendations.  This compares favourably 
with a recent investigation involving elite Caucasian athletes from Australia [8].  Our data, 
however, demonstrates that almost 1 in 10 Arabic, 1 in 6 Black and 1 in 11 Caucasian athletes 
would still require further investigation using the Seattle Criteria, primarily due to the presence 
of RAE (31.8%), LAE (13.1%), LAD (5.2%), RAD (3.1%) and RVH (1.4%), either in isolation 
or in association with a recognised training related ECG change.  
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Using HCM, ARVC and pulmonary hypertension populations as a comparison group, both Zaidi 
et al. [17] and Gati et al. [18] have demonstrated that in asymptomatic athletes, the presence of 
RAE, LAE, LAD, RAD and RVH either in isolation or in association with a recognised training 
related ECG changes correlate extremely poorly with serious cardiac pathology.  Despite this, 
consensus opinion for the inclusion of these ECG parameters in both the ESC recommendations 
and the Seattle Criteria comes from the fact that these anomalies, in particular LAE, are common 
ECG features in HCM.  In HCM, however, they usually co-exist with multitude of other ECG 
abnormalities such as T-wave inversion, Q-waves and ST-segment depression [18]. Excluding 
these ECG parameters forms the basis of the Refined Criteria improving specificity and reducing 
the prevalence of an abnormal ECG in our cohort to 5.3% overall.  More strikingly, the Refined 
Criteria significantly improved the abnormal ECG prevalence in Black athletes to just 10% (vs. 
29.9% ESC and 16.6% Seattle Criteria), whilst it was further reduced to 3.6% and 2.1% in 
Arabic and Caucasian athletes respectively.  
 
Identification of Pathology 
Our study identified 7 athletes (0.4%) with HCM; with the prevalence in Black athletes five-
times greater than Arabic athletes (0.9 % vs. 0.2%).  No Caucasian athlete was diagnosed with 
HCM. HCM is cited as the leading cause of sudden death in young athletes [19], particularly 
within the Black population [20].  Importantly, all 3 ECG interpretation guidelines identified all 
7 HCM athletes with 100% sensitivity.  Our incidence rates in the present study from a cohort of 
1718 athletes who underwent systematic ECG and echocardiography are similar to those 
reported in previous screening studies involving Black and Arabic athletes, who report a disease 
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incidence of 1% and 0.5% respectively [6].  Whilst the incidence of HCM in Black athletes is 
still approximately 9-times higher than that observed in Caucasian athletes; our Arabic athletes 
now report similar HCM incidence rates to that of Caucasians, estimated at 0.1% [21]. 
 
A further 29 (1.2%) athletes were identified as having a congenital/valvular abnormality. 
Specifically, bicuspid aortic valve (n=7, 0.3%), mitral valve prolapse (n=3, 0.1%), mild aortic 
regurgitation (n=5, 0.2%), mitral regurgitation (mild) (n=2, 0.1%), atrial septal defect (n=6, 
0.2%) and one case of dextrocardia (0.04%); all picked up through auscultation.  None of these 
athletes was restricted from competition.  Only one of these cases was identified via an abnormal 
ECG (dextrocardia).  This poor sensitivity underscores the importance of a physical examination 
within the cardiovascular screening remit.        
 
Limitations 
Our results are based on observational cross-sectional data.  The potential for a false negative 
result exists even though 90-95% of individuals with HCM and 80% with ARVC exhibit ECG 
abnormalities [22, 23].  Furthermore, without serial examination over many years, it is near 
impossible to ascertain if asymptomatic athletes without a family history of SCD presenting with 
isolated LAD/RAD or LAE/RAE would later go onto develop a cardiomyopathy. Secondly, our 
population was exclusively male, limiting the application of our data to the female athletic 
population.  
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In the present study one athlete, a 27-year old black football player from South America died 
unexpectedly. At the time of pre-participation screening, the athlete reported no cardiovascular 
symptoms and no family history of SCD. ECG and echocardiography were strictly normal. The 
athlete self-presented to the emergency department complaining of severe abdominal pain and 
died several hours later. An autopsy was performed but the report has not been made available to 
the authors.  
 
Conclusion 
The 2014 Refined Criteria outperformed both the 2013 Seattle Criteria and the 2010 ESC 
recommendations by significantly reducing the number of false-positive ECGs in Arabic, Black 
and Caucasian male athletes whilst remaining 100% sensitive in identifying all athletes with 
cardiac pathology associated with SCD.  The 2014 Refined Criteria can not only be successfully 
applied to Black and Caucasian athletes, but also to Arabic athletes, helping to reduce both 
further investigation rates and the potential for unnecessary disqualifications, whilst maintaining 
sensitivity for conditions that may predispose athletes to SCD. 
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Table 1: Electrocardiographic parameters used to define various ECG abnormalities in the European Society of Cardiology 
recommendations, Seattle criteria and Refined Criteria.  
ECG Abnormality  European Society of Cardiology 
Recommendations 
Seattle Criteria Refined Criteria 
Left atrial enlargement  Negative portion of the P wave in 
lead V1 ≥0.1mV in depth and ≥40 
msec in duration 
Prolonged P wave duration of >120 
msec in leads I or II with negative 
portion of the P wave ≥0.1mV in 
depth and ≥40 msec in duration in 
lead V1 
As ESC 
Right atrial enlargement  P-wave amplitude ≥2.5mm in 
leads II, III or aVF 
As ESC As ESC 
Left QRS-axis deviation  -30O to -90O As ESC As ESC 
Right QRS-axis deviation  >115O >120O As ESC 
Right ventricular 
hypertrophy  
Sum of R wave in V1 and S wave 
in V5 or V6 ≥1.05 mV 
Sum of R wave in V1 and S wave 
in V5>1.05mV and right axis 
deviation >120O 
As ESC 
Corrected QT interval >440 msec (males) and >460 msec 
(females) 
>470 msec (males) and 480 msec 
(females) 
As Seattle 
Complete left bundle 
branch block  
QRS ≥120 msec predominantly 
negative QRS complex in lead V1 
(QS or rS), and upright 
monophasic R wave in leads I & 
V6 
As ESC As ESC 
Complete right bundle 
branch block  
RSR’ pattern in anterior precordial 
leads with QRS duration 
≥120msec 
Not relevant As ESC 
Intraventricular 
conduction delay  
Any QRS duration >120msec 
including RBBB and LBBB 
Any QRS duration ≥140 msec or 
complete LBBB 
As ESC 
Pathological Q-wave  >0.4mV deep in any lead except 
III, aVR 
>0.3mV deep and/or >40 msec 
duration in ≥2 leads except III and 
aVR 
≥40 msec in duration or ≥25% 
of the height of the ensuing R-
wave 
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Significant T-wave 
inversion  
≥2 mm in ≥2 adjacent leads (deep) 
or ‘minor’ in ≥2 leads 
>1 mm in depth in two or more 
leads V2−6, II and aVF or I and 
aVL (excludes III, aVR and V1) 
As Seattle 
ST-segment depression  ≥0.5 mm deep in ≥2 leads As ESC As ESC 
Ventricular pre-excitation  PR interval <120 msec with or 
without delta wave 
PR interval <120 msec with delta 
wave 
As Seattle 
LBBB, left bundle branch block; mm, millimetres; msec, milliseconds; RBBB, right bundle branch block 
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Table 2: Performance comparison of 3 ECG interpretation criteria (ESC recommendations vs. Seattle Criteria vs. Refined 
Criteria)  
 Combined  
(n=2491) 
Arabic  
(n=1367) 
Black  
(n=748) 
Caucasian  
(n=376) 
Prevalence of an abnormal ECG 
using ESC recommendations 
555 (22.3%) 261 (19.1%) 224 (29.9%) 70 (18.6%) 
Prevalence of an abnormal ECG 
using Seattle Criteria 
289 (11.6%) 133 (9.7%) 124 (16.6%) 32 (8.5%) 
Prevalence of an abnormal ECG 
using Refined Criteria 
132 (5.3%) 49 (3.6%) 75 (10%) 8 (2.1%) 
Number of identified conditions 
associated with SCD  
10 
(7 HCM; 3 WPW) 
4  
(2 HCM; 2 WPW) 
6  
(5 HCM; 1 WPW) 
0 
FPR when using ESC 
recommendations 
21.9% 18.8% 29.1% 18.6% 
FPR when using Seattle Criteria 
 
11.2% 9.4% 15.8% 8.5% 
FPR when using Refined Criteria 4.9% 3.3% 9.2% 2.1% 
ECG; electrocardiogram, ESC; European Society of Cardiology, SCD; sudden cardiac death, HCM; hypertrophic cardiomyopathy, 
WPW; wolff-parkinson-white syndrome and FPR; false positive rate 
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Table 3: Table representing the sensitivity and specificity and likelihood ratios of 3 ECG 
interpretation criteria 
 ESC  
recommendations 
Seattle 
Criteria 
Refined  
Criteria 
Combined athletes: 
Arabic, Black and Caucasian 
 +ve 
ECG  
-ve 
ECG 
 +ve 
ECG  
-ve 
ECG 
 +ve 
ECG  
-ve 
ECG 
+ve path. 10 0 +ve path. 10 0 +ve path. 10 0 
-ve path. 400 1308 -ve path. 213 1495 -ve path. 102 1606 
Positive predictive value (%) 
[95% CI] 
2.4 
[1.2 - 4.4] 
4.5 
[2.2 - 8.1] 
8.9 
[4.37 - 15.81] 
Sensitivity (%)  
[95% CI] 
100 
[69.0 - 100] 
100 
[69.0 - 100] 
100 
[69.0 - 100] 
Specificity (%)  
[95% CI] 
76.6 
[74.5 - 78.6] 
87.5* 
[85.9 - 89.1] 
94.0*† 
[92.8 - 95.1] 
Positive likelihood ratio  
[95% CI] 
4.3 
[3.9 - 4.7] 
8.0* 
[7.1 - 9.1] 
16.8*† 
[13.9 - 20.2] 
    
Black athletes 
 
 +ve 
ECG 
-ve 
ECG 
 +ve 
ECG 
-ve 
ECG 
 +ve 
ECG 
-ve 
ECG 
+ve path. 6 0 +ve path. 6 0 +ve path. 6 0 
-ve path. 168 383 -ve path. 90 461 -ve path. 54 497 
Positive predictive value (%) 
[95% CI] 
3.4 
[1.3-7.4] 
6.2 
[2.3-13.1] 
10 
[3.8-20.5] 
Sensitivity (%)  
[95% CI] 
100 
[54.1 -100] 
100 
[54.1 -100] 
100 
[54.1 -100] 
Specificity (%)  
[95% CI] 
69.5 
[65.5 -73.3] 
83.7 
[80.3 -86.7] * 
90.2 
[87.4 -92.5] *† 
Positive likelihood ratio  
[95% CI] 
3.3 
[1.8 to 3.6] 
6.1 
[3.2 to 7.1] * 
10.2 
[5.3 to 12.5] *† 
    
Arabic athletes 
 
 +ve 
ECG 
-ve 
ECG 
 +ve 
ECG 
-ve 
ECG 
 +ve 
ECG 
-ve 
ECG 
+ve path. 4 0 +ve path. 4 0 +ve path. 4 0 
-ve path. 185 750 -ve path. 104 831 -ve path. 41 894 
Positive predictive value (%) 
[95% CI] 
2.1 
[0.6-5.3] 
3.7 
[1.0-9.2] 
8.9 
[2.5-21.2] 
Sensitivity (%) 
[95% CI] 
100 
[39.8 - 100] 
100 
[39.8 -100] 
100 
[39.8 -100] 
Specificity (%)  
[95% CI] 
80.2 
[75.6-82.7] 
88.9* 
[86.7-90.8] 
95.6*† 
[94.1-96.8] 
Positive likelihood ratio  
[95% CI] 
5.1 
[12.2-5.4] 
9.0* 
[3.8-10.1] 
22.8*† 
[9.4-28.8] 
ESC; European Society of Cardiology, +ve ECG; abnormal electrocardiogram, -ve ECG; normal 
electrocardiogram, +ve path; identified cardiac pathology, -ve path; no identified cardiac pathology. * 
Significantly different from ESC recommendations. †Significantly different from Seattle Criteria 
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Figure 1.  Definition of an abnormal ECG using the Refined criteria 
